Current trends in theranostics for rheumatoid arthritis.

Area of Science:

• Nanomedicine
• Biotechnology
• Rheumatology

Background:

• Rheumatoid Arthritis (RA) presents complex prognosis and management challenges due to late-stage manifestations and irreversible bone/cartilage damage.
• Early diagnosis is critical to prevent RA complications and disabilities.
• Current diagnostic techniques and treatments have limitations in efficacy and targetability.

Purpose of the Study:

• To review the role of theranostics in addressing the challenges of RA diagnosis and management.
• To summarize laboratory studies on theranostic entities for RA and discuss their outcomes.
• To highlight the potential of nanotechnology-based theranostics for improved RA care.

Main Methods:

• Review of laboratory studies on various nanoplatforms for RA theranostics.
• Analysis of novel platforms including gold nanorods, nanoshells, magnetic nanoparticles, and silica nanoparticles.
• Discussion of theranostic applications such as photodynamic therapy, chemo-photo responsiveness, and magnetic field-based imaging.

Main Results:

• Nanotechnology enables theranostic platforms with enhanced targetability and performance for RA.
• Various nanoplatforms demonstrate promising results in RA diagnosis and treatment.
• Theranostics facilitate personalized treatment selection and monitoring of therapeutic response in RA patients.

Conclusions:

• Theranostics offer a significant advantage over current diagnostic and treatment methods for Rheumatoid Arthritis.
• Nanotechnology-driven theranostics hold great potential for advancing RA disease management.
• Personalized medicine approaches using theranostics can improve patient outcomes in RA.